metr-nk cell
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2024 (NCT06395844)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, passive
Tumor antigens immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07096583 | Phase 1/Phase 2 (Phase 2) | Jul 7, 2025 | Anhui Medical University, Government of China |
| NCT06884345 | Phase 1/Phase 2 (Phase 2) | Mar 13, 2025 | Anhui Medical University |
| NCT06395844 | Phase 1/Phase 2 (Phase 2) | May 1, 2024 | Anhui Medical University, Government of China |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Medical University | Academic/Hospital | 3 | 3 | 1 | 2024 |
| Government of China | Government | 2 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1